WINDTREE THERAPEUTICS INC /DE/

WINT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
Assets
Cash & Equivalents $1.8M $4.3M $6.2M $22.3M $16.9M $22.6M $11.2M $1.8M
Accounts Receivable
Inventory
Total Current Assets $2.6M $5.4M $7.4M $23.5M $18.1M $23.9M $25.7M $2.2M
Property, Plant & Equipment $111.0K $183.0K $262.0K $1.0M $924.0K $798.0K $802.0K $885.0K
Goodwill $0 $3.1M $15.7M $15.7M $15.7M $15.7M
Intangible Assets (Excl. Goodwill) $9.7M $17.0M $77.1M $77.1M $77.1M
Total Assets $27.9M $32.4M $38.0M $74.8M $112.9M $119.0M $119.4M $3.3M
Liabilities
Accounts Payable $1.9M $809.0K $249.0K $693.0K $1.2M $1.7M $3.4M $2.3M
Total Current Liabilities $5.7M $4.0M $2.5M $4.9M $6.1M $7.8M $20.6M $11.8M
Long-Term Debt
Total Liabilities $14.7M $29.0M $27.9M $32.9M $43.3M $44.0M $51.3M $27.3M
Stockholders' Equity
Retained Earnings $-846.6M $-844.8M $-824.5M $-785.3M $-717.7M $-685.1M $-657.6M $-637.1M
Total Stockholders' Equity $10.0M $3.4M $10.0M $41.9M $69.6M $74.9M $68.1M $-23.9M
← Newer Page 1 of 2 Older →